You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 2, February 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  PAPERS READ BEFORE THE SEVENTH ANNUAL MEETING OF THE SURGICAL INFECTION SOCIETY, PHILADELPHIA, MAY 11 TO MAY 12, 1987-PART I
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

APACHE II Score and Abdominal Sepsis

A Prospective Study

John M. A. Bohnen, MD, FRCS(C); Robert A. Mustard, MD, FRCS(C); Susan E. Oxholm, RN; B. Diana Schouten, RN

Arch Surg. 1988;123(2):225-229.


Abstract

• Therapeutic trials for intra-abdominal sepsis require pretreatment stratification; physiologic scoring has been recently proposed for this purpose. We have prospectively tested the validity of one such scoring system, namely, the Acute Physiology and Chronic Health Evaluation (APACHE II). As part of a larger database, we correlated APACHE II scores with mortality in 100 patients hospitalized for generalized peritonitis or abdominal abscess. Use of steroids was recorded because of our suspicion that steroids increase mortality but blunt the physiologic response to sepsis. Thirty-one patients died, including 12 of 19 patients receiving steroids. Stepwise discriminant analysis revealed that the APACHE II score and steroid use were each independently associated with the rate of mortality. We report a prospective validation of pretreatment APACHE II scoring in abdominal sepsis. Steroid use is an independent risk factor.

(Arch Surg 1988;123:225-229)



Author Affiliations

From the Department of Surgery, The Wellesley Hospital (Drs Bohnen and Mustard and Mss Oxholm and Schouten), Toronto, and the University of Toronto (Drs Bohnen and Mustard).


Footnotes

Accepted for publication July 24, 1987.

Read before the Seventh Annual Meeting of the Surgical Infection Society, Philadelphia, May 11, 1987.

Reprint requests to Department of Surgery, The Wellesley Hospital, E. K. Jones Bldg, Room 204,106 Wellesley St E, Toronto, Ontario, Canada M4Y 1J3 (Dr Bohnen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comparison of On-Demand vs Planned Relaparotomy Strategy in Patients With Severe Peritonitis: A Randomized Trial
van Ruler et al.
JAMA 2007;298:865-872.
ABSTRACT | FULL TEXT  

Molgramostim (GM-CSF) Associated With Antibiotic Treatment in Nontraumatic Abdominal Sepsis: A Randomized, Double-blind, Placebo-Controlled Clinical Trial.
Orozco et al.
Arch Surg 2006;141:150-153.
ABSTRACT | FULL TEXT  

Prognostic Accuracy of Acute Physiology and Chronic Health Evaluation II Scores in Critically Ill Cancer Patients
Chang et al.
Am J Crit Care 2006;15:47-53.
ABSTRACT | FULL TEXT  

Evaluation of antimicrobial therapy management of 120 consecutive patients with secondary peritonitis
Sotto et al.
J Antimicrob Chemother 2002;50:569-576.
ABSTRACT | FULL TEXT  

Risk Stratification in Emergency Surgical Patients: Is the APACHE II Score a Reliable Marker of Physiological Impairment?
Koperna et al.
Arch Surg 2001;136:55-59.
ABSTRACT | FULL TEXT  

A Randomized, Double-blind Clinical Trial Comparing Cefepime Plus Metronidazole With Imipenem-Cilastatin in the Treatment of Complicated Intra-abdominal Infections
Barie et al.
Arch Surg 1997;132:1294-1302.
ABSTRACT  

Prognosis in Intra-abdominal Infections: Multivariate Analysis on 604 Patients
Pacelli et al.
Arch Surg 1996;131:641-645.
ABSTRACT  

Development of Multiple Organ Dysfunction Syndrome in Critically Ill Patients With Perforated Viscus: Predictive Value of APACHE Severity Scoring
Barie et al.
Arch Surg 1996;131:37-43.
ABSTRACT  

Comparison of APACHE II and III Scoring Systems for Mortality Prediction in Critical Surgical Illness
Barie et al.
Arch Surg 1995;130:77-82.
ABSTRACT  

Steroids, APACHE II Score, and the Outcome of Abdominal Infection
Bohnen et al.
Arch Surg 1994;129:33-38.
ABSTRACT  

Pneumonia Complicating Abdominal Sepsis: An Independent Risk Factor for Mortality
Mustard et al.
Arch Surg 1991;126:170-175.
ABSTRACT  

Percutaneous Catheter Drainage of Infected Pancreatic and Peripancreatic Fluid Collections
Adams et al.
Arch Surg 1990;125:1554-1557.
ABSTRACT  

Comprehensive Management of Acute Necrotizing Pancreatitis and Pancreatic Abscess
Stanten and Frey
Arch Surg 1990;125:1269-1275.
ABSTRACT  

Peritoneal Lavage in Abdominal Sepsis: A Controlled Clinical Study
Schein et al.
Arch Surg 1990;125:1132-1135.
ABSTRACT  

The Effect of Preexisting Conditions on Mortality in Trauma Patients
Morris et al.
JAMA 1990;263:1942-1946.
ABSTRACT  

APACHE II Score in Abdominal Sepsis
SCHEIN
Arch Surg 1988;123:1288-1288.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.